Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease
Clinical trial NCT05565092 · TERMINATED
Trial details
- NCT number
- NCT05565092
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2024-01-09
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.